Inflammation has been found to play a major role in breast cancer development through the activation of transcription factor NF-κB.NF-κB, a transcription
Trastuzumab(Tr) is able to induce molecular changes in Her2 + breast cancer cells that makethem to induce an antigen specific cytotoxic T cell (CTL) respons